Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Total article views   HTML views PDF downloads Totals
15,853 Dovepress* 9,849+ 2,280 12,129
PubMed Central* 6,004 655 6,659
Totals 15,853 2,935 18,788
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar